Antibodies don't work.
NLRP3 is by far the most studied inflammasome — yet <30% of commercial antibodies were specific.
Only 4 of 14 tested antibodies detected NLRP3 specifically.
Antibodies must be validated before use.
Full report by @ycharos.bsky.social : zenodo.org/records/1162...
